Westwood Holdings Group
ALPN icon

Westwood Holdings Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Westwood Holdings Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,799
Closed -$450K – 512
2023
Q2 		$450K Buy
+43,799
New +$395K ﹤0.01% 410
2022
Q1 		– Sell
-23,079
Closed -$319K – 486
2021
Q4 		$319K Buy
+23,079
New +$286K ﹤0.01% 410

Other funds holding ALPN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westwood Holdings Group's ALPN Position: Q3 2023 in Review

Westwood Holdings Group sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2023, closing a stake of 43,799 shares — an estimated $450K sold.

Westwood Holdings Group first reported a position in ALPN in Q4 2021 and held it in 2 quarters. The position peaked at $450K in Q2 2023. 88 funds tracked by Wall St. Rank hold ALPN as of Q3 2023.

  • Westwood Holdings Group reported no remaining Alpine Immune Sciences Inc position as of Q3 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 43,799 Alpine Immune Sciences Inc shares in Q3 2023, an estimated $450K.
  • Westwood Holdings Group first reported a position in Alpine Immune Sciences Inc in Q4 2021 and held it in 2 quarters.
  • Westwood Holdings Group's Alpine Immune Sciences Inc position peaked at $450K in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2023.

Based on Westwood Holdings Group's 13F filing for Q3 2023, filed 14 Nov 2023.